Research suggests that GLP-1 medications may reduce this harmful fat depot as part of overall weight loss, though the mechanisms remain incompletely understood
The 33-page lawsuit says Zenwise does not disclose anywhere on product packaging or in marketing materials that its gas and bloating relief supplements cannot do what [Zenwise] claims they can do. The probiotics and digestive enzymes in the Zenwise supplements at issue have been shown through research to be ineffective at combatting gas and bloating, especially at the dosages at which they exist in the products, the suit contests
Common GLP-1 medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Clin Psychopharmacol Neurosci
ISBN 978-3-540-28783-4
DOI: 10.1210/jendso/bvae164